Podcasts about Clinical

John Murray, Ian Dennis & Ali Bruce-Ball talk football, travel & language. They debate the FA Cup schedule and lack of free-to-air matches, as well as Ruben Amorim and Enzo Maresca losing their jobs. There's a twist in the first Clash of the Commentators of the year. More unintended pub and film names, and which commentary phrases will end up in our Great Glossary? Suggestions welcome on WhatsApp voicenotes to 08000 289 369 & emails to TCV@bbc.co.uk02:00 Quiz controversy leaves scars 08:15 FA Cup commentaries this weekend 10:55 Should all the matches kick-off at three? 23:00 TCV on Amorim & Maresca 31:00 Back to square one 36:20 Unintended pub and film names 41:20 Clash of the Commentators 46:25 Great Glossary of Football Commentary5 Live / BBC Sounds commentaries:Fri 9 Jan FA CUP: Wrexham v Nottingham Forest 1930 - 5 LIVE. FA CUP: Preston v Wigan 1930 - SPORTS EXTRA.Sat 10 Jan WSL: Arsenal v Man Utd 1230 - SPORTS EXTRA. FA CUP: Macclesfield v Crystal Palace 1215 - 5 LIVE. FA CUP: Everton v Sunderland 1215 - SPORTS EXTRA 2. FA CUP: Wolves v Shrewsbury 1215 - SPORTS EXTRA 3. FA CUP: Fulham v Middlesbrough 1500 - 5 LIVE. FA CUP: Man City v Exeter 1500 - SPORTS EXTRA. FA CUP: Newcastle v Bournemouth 1500 - SPORTS EXTRA 2. FA CUP: Stoke v Coventry 1500 - SPORTS EXTRA 3. FA CUP: Spurs v Aston Villa 1745 - 5 LIVE. FA CUP: Bristol City v Watford 1745 - SPORTS EXTRA. FA CUP: Cambridge v Birmingham 1745 - SPORTS EXTRA 2. FA CUP: Grimsby v Weston-super-mare 1745 - SPORTS EXTRA 3. FA CUP: Charlton v Chelsea 2000 - 5 LIVE.Sun 11 Jan FA CUP: Derby v Leeds 1200 - 5 LIVE. FA CUP: Portsmouth v Arsenal 1400 - 5 LIVE. FA CUP: West Ham v QPR 1430 - SPORTS EXTRA. FA CUP: Norwich v Walsall 1430 - SPORTS EXTRA 2.Mon 12 Jan FA CUP: Liverpool v Barnsley 1945 – 5 LIVE.Great Glossary of Football Commentary:DIVISION ONE Back to square one, Blaze over the bar, Bosman, Cruyff Turn, Cultured/educated left foot, Dead-ball specialist, Fox in the box, Giving the goalkeeper the eyes, Head tennis, Hibs it, In a good moment, In behind, The Maradona, Off their line, Olimpico, Onion bag, Panenka, Park the bus, Perfect hat-trick, Rabona, Roy of the Rovers stuff, Schmeichel-style, Scorpion kick, Spursy, Tiki-taka, Where the kookaburra sleeps, Where the owl sleeps, Where the spiders sleep. DIVISION TWO Ball stays hit, Beaten all ends up, Business end, Came down with snow on it, Catching practice, Camped in the opposition half, Cauldron atmosphere Coat is on a shoogly peg, Come back to haunt them, Corridor of uncertainty, Couldn't sort their feet out, Easy tap-in, Daisy-cutter, First cab off the rank, Good leave, Half-turn, Has that in his locker, High wide and not very handsome, Hospital pass, Howler, In their pocket, Johnny on the spot, Leading the line, Nice headache to have, Nutmeg, One for the cameras, One for the purists, Played us off the park, Points to the spot, Prawn sandwich brigade, Purple patch, Put their laces through it, Reaches for their pocket, Rolls Royce, Root and branch review, Row Z, Screamer, Seats on the plane, Show across the bows, Slide-rule pass, Steal a march, Straight in the bread basket, Stramash, Taking one for the team, Telegraphed that pass, That's great… (football), Thunderous strike, Turns on a sixpence, Walk it in. UNSORTED 2-0 is a dangerous score, After you Claude, All-Premier League affair, Aplomb, Bag/box of tricks, Brace, Brandished, Bread and butter, Breaking the deadlock, Bundled over the line, Champions elect / champions apparent, Clinical finish, Commentator's curse, Coupon buster, Denied by the woodwork, Draught excluder, Elimination line, Fellow countryman, Foot race, Formerly of this parish, Free hit, Goalkeepers' Union, Goalmouth scramble, Good touch for a big man, Honeymoon Period, In and around, In the shop window, Keeping ball under their spell, Keystone Cops defending, Languishing, Loitering with intent, Marching orders, Nestle in the bottom corner, Numbered derbies, Opposite number, PK for penalty-kick, Postage stamp, Put it in the mixer, Rasping shot, Red wine not white wine, Relegation six-pointer, Rooted at the bottom, Route One, Sending the goalkeeper the wrong way, Shooting boots, Sleeping giants, Slide rule pass, Small matter of, Spiders web, Stayed hit, Steepling, Stinging the palms, Stonewall penalty, Straight off the training ground, Taking one for the team, Team that likes to play football, Throw their cap on it, Thruppenny bit head / 50p head, Towering header, Two good feet, Turning into a basketball match, Turning into a cricket score, Usher/Shepherd the ball out of play, Walking a disciplinary tightrope, Wand of a left foot, We've got a cup tie on our hands, Wrap foot around it, Your De Bruynes, your Gundogans etc.

This episode offers a practical, case-based overview of evaluating and managing anastomotic leaks in colorectal surgery. It highlights early clinical warning signs, optimal imaging, and a framework for choosing nonoperative versus operative strategies, including when to drain, divert, repair, or revise an anastomosis. The discussion also covers management considerations in diverted patients and those with Crohn's disease, as well as long-term issues such as chronic leak–related complications and planning for stoma reversal. Join Drs. Jared Hendren, Elissa Dabaghi, Joseph Trunzo, Ajaratu Keshinro, and David Rosen as they discuss this clinical challenge in colorectal surgery.Hosts: - Jared Hendren, MDο      Institution: Department of General Surgery, Digestive Disease Institute, Cleveland Clinic Foundation, Cleveland, Ohio- Elissa Dabaghi, MDο      Institution: Department of General Surgery, Digestive Disease Institute, Cleveland Clinic Foundation, Cleveland, Ohio- Joseph Trunzo, MDο      Institution: Department of Colon and Rectal Surgery, Digestive Disease Institute, Cleveland Clinic Foundation, Cleveland, Ohioο      Social Media Handle: X/Twitter @joseph_trunzo- Ajaratu Keshinro, MDο      Institution: Department of Colon and Rectal Surgery, Digestive Disease Institute, Cleveland Clinic Foundation, Cleveland, Ohioο      Social Media Handle: X/Twitter- @AJKesh-  David Rosen, MDο      Institution: Department of Colon and Rectal Surgery, Digestive Disease Institute, Cleveland Clinic Foundation, Cleveland, Ohio- Social Media Handle: X/Twitter- @davidrrosenmdLearning Objectives: By the end of this episode, listeners will be able to: Assess postoperative changes that warrant imaging and/or intervention in suspected anastomotic leaks. Apply a structured decision-making approach to determine when nonoperative management, drainage, diversion, or operative intervention is most appropriate. Recognize key considerations in managing leaks in diverted patients and those with Crohn's disease, including long-term complications and factors influencing stoma reversal planning. Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.  If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listenBehind the Knife Premium:General Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-reviewTrauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlasDominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkshipDominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotationVascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-audio-reviewColorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-audio-reviewSurgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-audio-reviewCardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-audio-reviewDownload our App:Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US

I'm gonna do a little series here called "The Inches Are All Around Us," and in this series, at least to start, all of the inches I'm gonna mention are full-on administrative waste—waste that is particularly egregious because it has nothing to do with patient care. That's why when Shane Cerone said, "The inches are all around us" in episode 492 about hospitals and hospital prices, I really perked up. Because by fixing this friction, this administrative waste, we can actually improve patient care and reduce costs simultaneously. For a full transcript of this episode, click here. If you enjoy this podcast, be sure to subscribe to the free weekly newsletter to be a member of the Relentless Tribe. Along these same lines, I have also heard Zack Cooper, PhD, talk about the 1% steps to healthcare reform project, where he's like, look, find 10 or 30 or whatever 1% problems, and you'll probably transform healthcare faster than if you're trying to find a 10% or 30% solution. So, same idea. And finding these inches, these 1 percents, even in and of themselves, it's big dollars when it comes to how much the U.S. spends on healthcare, which is, by the way, projected to reach $5.6 trillion in 2025, according to NHE (National Health Expenditure) projections from federal actuaries. So, I decided to go on a bit of a quest for these inches—you know, get a bead on where they may be nestled for anyone looking on behalf of their plan or their country or their state maybe. To this end, also recall or be aware of the episode with David Scheinker, PhD (EP363). But David Scheinker in that episode gets into how much every industry pays something like 2% to administer a transaction. But in healthcare, the provider pays something like 14%, and the payer pays another 14% to submit and get paid for a claim, which is healthcare for a transaction. Don't get me wrong, it's the plan sponsors such as self-insured employers, members, and USA taxpayers who are ultimately paying for those two 14 percents. So that 28% of full-on administrative costs—most of which, we could agree, could go away and probably be better for patients, not worse—this, too, is coming out of the pockets of the ultimate purchasers of healthcare. Those costs are getting passed along. I say all this to say, to kick off this "the inches are all around us" exploration, I wanted to dig in a little more specifically into what goes on during these aforementioned transactions (ie, what this life of a claim kind of, like, looks like on the ground). I wanted to start here because, yeah, we haven't done this before; and this exploration is gonna continue into next week because we're gonna dip heavy into clearinghouses with Zack Kanter and what they do all day. And then after that, I'm talking payment integrity programs. I'm talking prepayment review programs with Mark Noel, because you know what? Employers don't wanna be bringing a knife to a gunfight. And I realized in the course of these conversations that any self-insured plan sponsor that is not doing, for real, payment integrity programs, for real, prepayment review, post-payment review.  I'm getting ahead of myself, but when you listen to the show next week with Zack Kanter, you will so totally see what I mean. Today, as I mentioned earlier, I am speaking with Mark Newman, who is the CEO and founder of Nomi Health. Nomi aims to simplify the act of buying and paying for healthcare for self-insured employers. Look 'em up if that sounds intriguing. I also do need to thank Nomi Health for so generously offering to donate to RHV to cover the expenses of producing this episode. So, thank you so much to Nomi Health. Okay, lastly here, just to set the basic framework for this conversation that follows, Mark gets into two main revelations, reasons that kind of sit behind all a large part of the waste and friction in healthcare transactions. Again, otherwise known as a claim getting paid. And these two reasons are data isn't data isn't data. In other words, as a claim moves through the system to different stakeholders, the data starts to change and morph and come and go. Different people have different use cases for that data, so it starts to get added and subtracted, but nobody really has the universal level to tote up the difference in any organized fashion. So, we talk about that first. Then Mark Newman doubles down with another reason for the friction and waste. Here's the second revelation: A dollar isn't a dollar isn't a dollar. And same kind of rules apply here. A plan sponsor might spend a dollar and, yeah, is that dollar spent or is that dollar accrued to spend? Which is kind of wonky, but also relevant. And if you didn't understand that, we'll get to it. And then just because a dollar gets spent doesn't mean the provider gets that dollar. And by the way, I don't just mean, oh, there's spread pricing. How shocking. I mean that a plan sponsor could roll up to a hospital and say, "We spent $10 million last year," and the hospital could say, "No, you didn't. You only spent five." And spoiler alert, in this case, it's not about spread pricing, although it might be. It's also about how much was the member responsibility that the members didn't pay. So, a dollar is not a dollar for a whole bunch of different reasons. This podcast is sponsored by Aventria Health Group, and today, it's also sponsored by Nomi Health. Also mentioned in this episode are Nomi Health; Shane Cerone; Zack Cooper, PhD; David Scheinker, PhD; Zack Kanter; Mark Noel; Aventria Health Group; Preston Alexander; Eric Bricker, MD; Sam Flanders, MD; Andrew Tsang; Sandra Raup; Stan Schwartz, MD; ZERO.health; Cristin Dickerson, MD; and Matt Christensen. For a list of healthcare industry acronyms and terms that may be unfamiliar to you, click here.   You can learn more at nomihealth.com or reach out to Mark at mark@nomihealth.com. You can also follow Mark and Nomi Health on LinkedIn.   Mark Newman is the co-founder and CEO of Nomi Health, on a mission to rebuild America's healthcare system to serve all stakeholders: providers, employers, and patients. A recognized healthcare innovator and entrepreneur, Mark previously founded and built HireVue into the world's largest provider of AI-driven talent assessment solutions before its acquisition by the Carlyle Group. His commitment to improving the healthcare system stems from a desire to address systemic issues that have long plagued the industry. Under his leadership since its inception in 2019, Nomi Health has focused on creating a more direct and transparent healthcare experience: reducing an organization's spend by over 30% per patient while increasing a provider's payments. Through Nomi Health, Mark continues to advocate for a more efficient, service-centered approach to healthcare that prioritizes known costs for employers, zero out of pocket for patients, and near-real-time payments for providers.   06:48 What is actionable to know about the life of a claim? 08:14 How data can change as it moves through the claims process. 11:45 Why a dollar isn't a dollar in healthcare. 18:50 Why employers are actually paying more than a dollar to access a dollar of healthcare (the medical loss ratio). 21:54 Why cutting out the "friction" is actually better for employees and members. 22:48  EP482 with Preston Alexander. 22:50 EP472 with Eric Bricker, MD. 23:36  EP490 and EP492 with Sam Flanders, MD, and Shane Cerone. 23:53 Infographic by Andrew Tsang showing 27 streams of income. 26:53 How do we fix these issues? 28:05 LinkedIn comment from Sandra Raup. 28:59 How Nomi Health is experimenting with a no co-payment, no deductible model. 31:29 INBW42 with Stacey on moral hazard. 32:26 EP486 with Stan Schwartz, MD. 32:31  EP485 with Cristin Dickerson, MD. 32:56 The Innovator's Dilemma by Clayton M. Christensen. 34:55 How does Nomi Health work with and help employers?   You can learn more at nomihealth.com or reach out to Mark at mark@nomihealth.com. You can also follow Mark and Nomi Health on LinkedIn.   @markhirevue discusses #plansponsor #healthspend and #clinicalorg pay on our #healthcarepodcast. #podcast #financialhealth #patientoutcomes #primarycare #digitalhealth #healthcareleadership #healthcaretransformation #healthcareinnovation   Recent past interviews: Click a guest's name for their latest RHV episode! Stacey Richter (INBW45), Stacey Richter (INBW44), Marilyn Bartlett (Encore! EP450), Dr Mick Connors, Sarah Emond (EP494), Sarah Emond (Bonus Episode), Stacey Richter (INBW43), Olivia Ross (Take Two: EP240), John Quinn

Send us a textIn this Journal Club episode, Ben and Daphna review a large national cohort study examining the association between antenatal corticosteroid exposure and survival in extremely preterm infants born between 21 and 24 weeks' gestation. They discuss biologic plausibility, practice variation, and the challenges of interpreting retrospective data, while focusing on how these findings may inform counseling and shared decision-making at the margins of viability.----The Effects of Antenatal Corticosteroids on Extremely Premature Neonates Born between 21 and 24 Weeks. Yao R, Tritch N, Vedhanayagam K, Ali N, Reimche-Vu H, Gedestad I, Karageuzian S, Contag S.Am J Perinatol. 2025 Nov 6. doi: 10.1055/a-2722-8107. Online ahead of print. PMID: 41086871Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

Still stuck in the “expensive hobby” phase? Wondering why your coaching business isn't bringing in consistent income—despite all your effort?If you're a clinician ready to make REAL money in your coaching business, this episode breaks down the one thing standing in your way: your offer.I reveal why your offer—not your content, pricing, or visibility—is the real constraint between you and a fully booked coaching business.You'll learn:The 4 elements that make up a six-figure offer (most clinicians miss at least 2 of these)5 signs your current offer is holding your business backWhy posting more isn't resulting in more clients- and what to focus on instead.Listen now and learn how to craft the offer that makes your coaching business take off. If you want help clarifying your offer- so it actually sells, book your Offer Audit. A free 30 min call where I will personally look at your offer. If you want my support in building and launching your offer, Create Your Six Figure Offer is the space for you. Learn more This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit spirituallyambitious.substack.com/subscribe

Dr. Kevin Fitzgerald, small animal veterinarian, author, stand-up comedian, and TV star, returns to the show this week to share an update on his memoir, It Started With A Turtle, and to take a look back on his 43-year veterinary career. He emphasizes kindness, community involvement, and lifelong learning as core values of veterinary medicine. And you don't want to miss the tale of "Beanie Boy" from his early days in practice!Thank you to our podcast partner Hill's Pet Nutrition! You can find more information about Hill's Pet Nutrition at Hill's Pet Nutrition - Dog & Cat Food Transforming Lives and Hill's Vet - Veterinary Health Research, Practice Management Resources.Remember, we want to hear from you! Please be sure to subscribe to our feed on Apple Podcasts and leave us a rating and review. You can also contact us at MVLpodcast@avma.orgFollow us on social media @AVMAVets #MyVetLife #MVLPodcast

Send us a textBen and Daphna review the ICAF randomized clinical trial evaluating extended caffeine therapy in preterm infants and its impact on intermittent hypoxia through 41 weeks postmenstrual age. They discuss the study design, oximetry outcomes across multiple saturation thresholds, inflammatory biomarkers including TNF-α, and clinically relevant safety signals such as oxygen restart rates, length of stay, and weight gain. The conversation focuses on what intermittent hypoxia may mean for ongoing risk, and whether a targeted subgroup of infants might benefit from extending caffeine beyond traditional stopping points.----Intermittent hypoxia and caffeine in infants born preterm: the ICAF Randomized Clinical Trial. Eichenwald E, Corwin M, McEntire B, Knoblach S, Limperopoulos C, Kapse K, Kerr S, Heeren TC, Ikponmwonba C, Hunt CE; ICAF Study Group.Arch Dis Child Fetal Neonatal Ed. 2025 Nov 24:fetalneonatal-2025-329230. doi: 10.1136/archdischild-2025-329230. Online ahead of print.PMID: 41285561Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

When everything depends on your real-time decisions, you can't replicate the progress, scale the outcomes, or lead others through your process. Even when it's working.In this episode, I share what that looked like in my own career.As a speech-language pathologist in the schools, I had the training and instincts to support students with complex language and learning needs. But when referrals surged and our team looked to me for leadership, I realized I didn't have a framework. My sessions were effective, but my tools weren't replicable. There was no way to take what was working and make it repeatable at the team, building, or district level.What started as a need in my own practice and doctoral work led to a research-informed framework that has now supported thousands of professionals across the country through my Language Therapy Advance Foundations program. Here's what we explore in this episode: • What it really costs to rely on instinct alone • Why generalization stalls without scalable systems in place • How “therapy homework” often lives inside what you're already doing • Why leadership begins long before you speak up in a meeting • How vocabulary can serve as a container for essential, transferable language skillsIf you're doing great work in direct language therapy sessions but struggling with generalization, this episode is for you.If your therapy is working, but hard to explain, scale, or share with your team, Language Therapy Advance Foundations will help you change that. You'll build a 5-component system that strengthens vocabulary, supports critical thinking, and works across goals and grade levels. Start building your framework today: https://drkarenspeech.com/languagetherapy

Join us on the latest episode, hosted by Jared S. Taylor!Our Guests: Dan D'Orazio, CEO, Sage Growth Partners, and Christina Speck, Chief Solutions & AI Officer, Sage Growth Partners.What you'll get out of this episode:Strategic AI Adoption: Leaders must align AI tools with real business problems, not just adopt technology for its own sake.Enterprise Change Management: Success hinges more on people and process readiness than on the AI technology itself.Human + AI Synergy: The rise of “HI + AI” and “HSI” (Humanist Super Intelligence) models puts empathy at the center of AI innovation.Clinical & Administrative Focus: Real AI excitement lies in automating repetitive administrative tasks, with clinical applications gaining cautious momentum.Sage's Growth-Centric AI Model: From readiness to impact, Sage Growth Partners tailors AI strategies to support each client's growth journey.To learn more about:Website http://www.sage-growth.comLinkedin https://www.linkedin.com/company/sage-growth-partners/Our sponsors for this episode are:Sage Growth Partners https://www.sage-growth.com/Quantum Health https://www.quantum-health.com/Show and Host's Socials:Slice of HealthcareLinkedIn: https://www.linkedin.com/company/sliceofhealthcare/Jared S TaylorLinkedIn: https://www.linkedin.com/in/jaredstaylor/WHAT IS SLICE OF HEALTHCARE?The go-to site for digital health executive/provider interviews, technology updates, and industry news. Listed to in 65+ countries.

In Season 2, Episode 7, Anne Hancock Toomey sits down with Lisa Shannon, CEO of Allina Health, to discuss her impressive trajectory from a rural community in Ohio to leading a health system with 12 hospitals and dozens of clinics across Minnesota and Wisconsin. Shannon began her career as a hospital-based dietician, growing and evolving to become a highly respected executive and leader. That success came from the early influence of her grandmother, along with, of course, mentors and leaders along the way. Shannon talks about a devastating medical error that affected her family early in her life. Indeed, one of Shannon's priorities throughout her leadership career has been the pursuit of zero safety events, which includes creating a culture where anyone and everyone is empowered to speak up. She also offers insights into balancing work and family and emphasizes the significance of listening to one's instincts in making career choices. 2:02 Early Life and Influences 4:42 First Jobs and Early Career 7:50 College and Career Path 15:36 Leadership Journey and Mentorship 16:58 Patient Safety and Cultural Change 21:38 Career Highlights and Challenges 30:59 Leadership Insights from the Role of CEO 35:04 Balancing Career and Family 39:43 Lightning Round and Closing Thoughts Learn more about your ad choices. Visit megaphone.fm/adchoices

According to the Guinness Book of World Records, TB is humanity's oldest contagious disease. It has become something of an afterthought in rich nations, but remains the world's most deadly infectious disease. In 2024 it killed more than 1.2 million people.South Africa has one of the highest TB burdens in the world, but it has also developed one of the most sophisticated scientific ecosystems for the study of the disease. Clinical trials conducted in the country have been crucial to the innovation of TB treatments, vaccines, diagnostics and prevention strategies.Much of the funding for this research comes from American institutions. But since early 2025, streams of that money have been withdrawn due to a series of decisions by the Trump administration.Sandra Kanthal visits Cape Town and discovers the story of two intertwined landscapes: the people in local communities struggling with the burden of tuberculosis, and the scientific institutions embedded in them trying to tackle the disease - and why at the moment both are struggling.This episode of The Documentary comes to you from Assignment, investigations and journeys into the heart of global events.

This is a Premium-exclusive episode of the podcast. To listen to the full episode you need to be subscribed to Sigma Nutrition Premium. Recently we (Danny Lennon & Alan Flanagan) were invited to 'Processing the Evidence', a "behind closed doors" workshop to discuss the latest scientific evidence on the role of processed foods in human health. The event was organized by Professors Ciarán Forde and Vincenzo Fogliano of Wageningen University in the Netherlands. The workshop attendees included a range of prominent researchers across a range of domains related to food processing, nutrition science, and public health. The sessions included open discussions on current evidence, knowledge gaps and challenges within the UPF debate. There were several structured sessions looking at different sub-topics, such as: Emulsifier-gut interactions Ultra-processing and its effect on food matrix and bioavailability Food liking and hedonic overeating UPFs: Interpreting nutritional epidemiology and RCTs New trial data: the PROMENADE trial, the RESTRUCTURE Trial, etc. In this episode, Alan and Danny review some of the key talking points and their takeaways from this event. Timestamps [00:31] Event overview: processing the evidence [04:44] Conference insights with Dr. Alan Flanagan [07:52] Hypotheses on ultra processed foods [11:53] Microbiome and additives panel [21:51] Food science and technology panel [33:21] Behavioral aspects of food consumption [38:10] Nutritional epidemiology session [47:19] Discussion on dietary pattern classification [50:19] The role of ultra-processed foods in public health policy [54:18] Clinical and metabolic data on processed foods [01:00:55] Critique of the NOVA classification system [01:08:03] Concluding thoughts on ultra-processed foods [01:23:12] Key ideas and methodological standpoints Related Resources Subscribe to Sigma Nutrition Premium Go to episode page Join the Sigma email newsletter for free Enroll in the next cohort of our Applied Nutrition Literacy course

According to the Guinness Book of World Records, TB is humanity's oldest contagious disease. It has become something of an afterthought in rich nations, but remains the world's most deadly infectious disease. In 2024 it killed more than 1.2 million people.South Africa has one of the highest TB burdens in the world, but it has also developed one of the most sophisticated scientific ecosystems for the study of the disease. Clinical trials conducted in the country have been crucial to the innovation of TB treatments, vaccines, diagnostics and prevention strategies.Much of the funding for this research comes from American institutions. But since early 2025, streams of that money have been withdrawn due to a series of decisions by the Trump administration. For Crossing Continents, Sandra Kanthal visits Cape Town and discovers the story of two intertwined landscapes: the people in local communities struggling with the burden of tuberculosis, and the scientific institutions embedded in them trying to tackle the disease - and why at the moment both are struggling.Presenter/Producer: Sandra Kanthal Producer in South Africa: Isa-Lee Jacobson Editor: Penny Murphy Sound Design: James Beard Production Coordinator: Katie Morrison

Featuring an interview with Dr Scott Kopetz, including the following topics: Circulating tumor DNA (ctDNA)-based molecular residual disease (MRD) and survival among patients with resectable colorectal cancer (CRC) in the CIRCULATE-Japan GALAXY trial (0:00) ctDNA for detection of MRD in patients with CRC in the BESPOKE CRC and INTERCEPT trials (3:11) Clinical utility of including ctDNA monitoring in standard CRC surveillance (11:11) ctDNA analysis guiding adjuvant therapy for CRC in the DYNAMIC and CIRCULATE-North America trials (15:52) CME information and select publications

About Michael Dubrovsky:Michael Dubrovsky is a founder-operator and applied scientist working at the intersection of materials science, photonics, and real-world impact. He is the co-founder and CEO of SiPhox Health, a Y Combinator (S20), Khosla Ventures, and Intel Capital–backed startup based in Cambridge, building painless at-home blood biomarker testing to help people live healthier, longer lives. Alongside SiPhox, he serves on the Clinical and Laboratory Standards Institute (CLSI) ILA20 committee and co-hosts 632nm, a technical interview series featuring top scientists and engineers. Previously, he co-founded PoWx, a nonprofit advancing energy-efficient photonic hardware for proof-of-work cryptography, work that is now used commercially to secure billions of dollars in value. Earlier in his career, Michael founded Simply Grid, named by Fast Company as one of the world's most innovative energy companies, deploying first-of-its-kind curbside EV and food-vendor charging infrastructure in New York City before exiting via acquisition. His background includes advanced research at MIT and Technion in nanofabrication and materials characterization and a BS in Chemistry from SUNY ESF. His personal mantra: no hurry, no pause.Things You'll Learn:At-home blood testing eliminates major barriers, such as appointments, referrals, and travel, while expanding access to advanced diagnostics. This convenience is driving higher adoption among both consumers and businesses.Many critical biomarkers linked to longevity and chronic disease are often ignored in standard primary care testing. Home testing allows patients to proactively monitor what would otherwise go unseen.Clinician trust remains a challenge due to early inaccuracies in home testing technologies. FDA clearance is expected to play a major role in broader medical acceptanceBusinesses benefit from home testing by eliminating high-friction steps that stall patient conversion. This leads to better experiences and significantly improved funnel performance.Scaling home diagnostics follows a familiar pattern where early adopters subsidize innovation. Over time, costs drop and access expands to broader populations.Resources:Connect with and follow Michael Dubrovsky on LinkedIn.Follow SiPhox Health on LinkedIn and visit their website.Listen to Michael's podcast on Apple Podcasts or Spotify.Email Michael directly here.

We discuss studies documenting the undertreatment of diabetic macular edema and possible strategies for alleviating it with Dr. Matthew Starr, Assistant Professor, Mayo Clinic, Rochester, Minnesota.

Ever feel powerless in the clinical environment? You're not alone - and you may have more power than you think. In this Clinical Challenges in Surgical Education, hosts Drs. Maya Hunt and Mckenzie Rowe explore power and leadership within surgical learning environments. Joined by guests Drs. Paula Ferrada, Chair of Surgery at Inova Fairfax, and Frances Mei Hardin, co-founder of the Hippocratic Collective, the team discusses frameworks of conceptualizing power, how it can be found at any point in training, and tips on how to identify and better wield our own power in learning environments. Episode Hosts: Dr. Maya Hunt, Indiana University, mayahunt@iu.edu    Dr. Mckenzie Rowe, Inova Fairfax, mckenzie.rowe@inova.org   CoSEF: @surgedfellows, cosef.org    Guests:  Dr. Paula Ferrada, Inova Fairfax, @pferrada1, paula.ferrada@inova.org Dr. Frances Mei Hardin, Hippocratic Collective, @francesmeimd, francesmei@hippocratic-collective.com Learning Objectives: Identify different sources of power within individuals Define framework of ‘power-over' vs. ‘power-to/power-with' Recognize how leaders (including residents) may wield different types of power in both harmful and helpful ways Spark self-reflection upon how each of us wields our own power in our role References: Brown B. Brené Brown on Power and Leadership. https://brenebrown.com/resources/brene-brown-on-power-and-leadership/.  Pansardi P, Bindi M. The new concepts of power? Power-over, power-to and power-with. Journal of Political Power. 2021;14(1):51-71. doi:10.1080/2158379x.2021.1877001  Bolman LG, Deal TE. Power, Conflict, and Coalition. In: Reframing Organizations: Artistry, Choice, and Leadership. 7th ed. Jossey-Bass; 2021:187-207.  Ferrada P. Breaking the silence: Addressing toxic leadership to restore psychological safety in healthcare. Forbes. October 8, 2025. https://www.forbes.com/councils/forbesbusinesscouncil/2025/10/08/breaking-the-silence-addressing-toxic-leadership-to-restore-psychological-safety-in-healthcare/.  Sponsor Disclaimer: Visit goremedical.com/btkpod to learn more about GORE® SYNECOR Biomaterial, including supporting references and disclaimers for the presented content. Refer to Instructions for Use at eifu.goremedical.com for a complete description of all applicable indications, warnings, precautions and contraindications for the markets where this product is available. Rx only Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listen Behind the Knife Premium: General Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-review Trauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlas Dominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkship Dominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotation Vascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-audio-review Colorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-audio-review Surgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-audio-review Cardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-audio-review Download our App: Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049 Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US

Today, I'm joined by Tim Rosa, CEO of Somnee. Pioneering personalized neurostimulation for sleep, Somnee's clinical-grade headband uses EEG brain mapping to help people get higher quality rest. In this episode, we discuss building the next generation of sleep technology. We also cover: Lessons from scaling Fitbit How EEG-driven neurostimulation works Traction with NBA athletes and elite performers Subscribe to the podcast → insider.fitt.co/podcast   Subscribe to our newsletter → insider.fitt.co/subscribe   Follow us on LinkedIn → linkedin.com/company/fittinsider   Somnee's Website: www.somneesleep.com  Instagram: https://www.instagram.com/somneesleep/  LinkedIn: https://www.linkedin.com/company/somnee/    -   The Fitt Insider Podcast is brought to you by EGYM. Visit EGYM.com to learn more about its smart fitness ecosystem for fitness and health facilities.   Fitt Talent: https://talent.fitt.co/  Consulting: https://consulting.fitt.co/  Investments: https://capital.fitt.co/   Chapters:  (00:00) Introduction  (01:29) Tim's background (02:13) Scaling Fitbit (03:00) Discovering Somnee  (04:15) Resetting the company (06:00) How Somnee works (07:15) Clinical-grade data (09:00) Sleep onset vs sleep maintenance (11:30) 15-minute sessions vs all-night tracking  (13:45) FDA clearance & clinical validation  (16:00) Go-to-market strategy (18:30) NBA, NFL, and elite athletes  (23:15) The sleep market opportunity (25:30) The future of wearables  (28:00) Device ecosystems and API integrations  (33:00) Series A fundraising (34:45) The 21-session optimization  (36:15) Where to find Somnee and learn more  (37:15) Conclusion  

In this conversation, Jessica Patterson and Florian Schmitzberger discuss the evolution of clinical practice guidelines (CPGs) from the Department of Defense (DOD) and their application in different contexts, particularly in light of the changes from the Global War on Terror (GWOT) to new healthcare environments. They emphasize the need for data to understand how these guidelines will perform in varied systems.TakeawaysThis isn't GWOT, this isn't Iraq, this isn't Afghanistan.Clinical practice guidelines (CPGs) evolved during GWOT.The performance of CPGs in different systems is uncertain.Data gathering is essential to assess guideline effectiveness.Understanding ground truth is crucial for guideline application.The DOD's CPGs were refined for specific contexts.New healthcare environments may challenge existing guidelines.The evolution of CPGs reflects changing military and healthcare needs.Questions arise about the adaptability of CPGs.Future research is needed to evaluate guideline performance.Chapters00:00 Introduction to the Podcast and Guests00:32 Data Collection and Research MethodologyFor more content, go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.prolongedfieldcare.org⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Consider supporting us: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠patreon.com/ProlongedFieldCareCollective⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ or ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.lobocoffeeco.com/product-page/prolonged-field-care⁠

In this week's episode of Full of Beans, Hannah is joined by Melanie Davies, a sleep and stress consultant and clinical hypnotherapist, to explore how hypnotherapy can support anxiety regulation, emotional overwhelm, and disordered eating patterns.Together, Hannah and Melanie unpack what hypnotherapy actually involves, how it works with the emotional and unconscious mind, and why nervous-system-based approaches may help when behaviour-focused treatments feel limiting or incomplete.This week, we discuss:What clinical hypnotherapy is and how it differs from stage hypnosisHypnosis as a naturally occurring state of focused attentionThe role of the unconscious mind in habits, urges, and emotional eatingAnxiety, stress responses, and food-related coping behavioursEmotional regulation as a foundation for sustainable habit changeHypnotherapy as a complementary approach alongside existing treatmentUsing imagination to support neural rewiring and behaviour changeAnchoring techniques to support self-soothing and nervous system calmingEvidence and emerging research in hypnotherapy, disordered eating, and IBSEthical practice, contraindications, and the importance of assessmentTimestamps02:10 – Why hypnosis isn't “mind control” and what actually happens in session05:40 – Focused attention, suggestibility, and everyday hypnotic states09:10 – Emotional drivers of binge urges, restriction, and food noise13:30 – Individualised treatment and why one-size-fits-all approaches fall short16:50 – Reconnecting with bodily cues, fullness, and interoceptive awareness20:30 – Supporting long-term change: maintenance, self-hypnosis, and autonomy24:10 – Calming cortisol, anchors, and nervous system retraining27:50 – Clinical evidence: bulimia, impulsive eating, IBS and the gut-brain axis33:20 – Integration with medical care, ethics, and suitability36:00 – Accessing support and next stepsResources & LinksVisit Melanie's website: MelanieDaviesMindSolutions.comConnect with Us:Subscribe to the Full of Beans PodcastFollow Full of Beans on InstagramCheck out our websiteListen on YouTube⚠️ Trigger Warning: Mentions of eating disorders, disordered eating behaviours, anxiety, and binge eating. Please take care when listening.If you enjoyed this episode, don't forget to subscribe, rate, and share the podcast to help us spread awareness.Sending positive beans your way, Han

Reagan Badger, Susan L Fink, Kathleen Hutchinson, Mark H Wener, Chihiro Morishima, Rebecca S Treger. Concurrent Anti-PR3 Immunoassay and cANCA Indirect Immunofluorescence Testing Provide Complementary Information for Clinical Laboratory Detection of Antineutrophil Cytoplasmic Antibodies. The Journal of Applied Laboratory Medicine, Volume 11, Issue 1, January 2026, Pages 83–97. https://doi.org/10.1093/jalm/jfaf168

Recording after the ball drops, Dr. Griffin and Vincent Racaniello wish everyone a Happy New Year, discuss an evidence-based approach to teaching and practice medicine and reminisce on the history of vaccine development and use before their discussion about the whooping cough outbreak of 2025 in the US and falling levels of tetanus vaccination, then Dr. Griffin then deep dives into recent statistics on the measles epidemic, RSV, influenza and SARS-CoV-2 infections, the Wasterwater Scan dashboard, Johns Hopkins measles tracker, how NY state reported the greatest number of influenza confirmed infections ever in one week during the week ending Dec 20,  where to find PEMGARDA, how to access and pay for Paxlovid, long COVID treatment center, where to go for answers to your long COVID questions, and contacting your federal government representative to stop the assault on science and biomedical research. Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode Evidence-Based Medicine: A New Approach to Teaching the Practice of Medicine (JAMA) The US has seen nearly 28,000 whooping cough cases this year. Here's what you need to know (CNN) Vaccine History: Developments by Year (CHOP, Children's hospital of Philadelphia: Vaccine History) Reported Incidence of notable diseases in United States: 1952 Morbidity and Mortality Weekly Report, Vol. 1, No. 54, October 26, 1953 (CDC: Stacks) As tetanus vaccination rates decline, doctors worry about rising case numbers (nbc News) Wastewater for measles (WasterWater Scan) Measles cases and outbreaks (CDC Rubeola) Tracking Measles Cases in the U.S. (Johns Hopkins) Measles vaccine recommendations from NYP (jpg) Weekly measles and rubella monitoring (Government of Canada) Measles (WHO) Get the FACTS about measles (NY State Department of Health) Measles (CDC Measles (Rubeola)) Measles vaccine (CDC Measles (Rubeola)) Presumptive evidence of measles immunity (CDC) Contraindications and precautions to measles vaccination (CDC) Adverse events associated with childhood vaccines: evidence bearing on causality (NLM) Measles Vaccination: Know the Facts(ISDA: Infectious Diseases Society of America) Deaths following vaccination: what does the evidence show (Vaccine) Influenza: Waste water scan for 11 pathogens (WastewaterSCan) US respiratory virus activity (CDC Respiratory Illnesses) Respiratory virus activity levels (CDC Respiratory Illnesses) New York State Department of Health Confirms Most Flu Cases Ever Recorded in One Week: New York State Reports 71,123 Flu Cases This Week (NY State Department of Health) Weekly surveillance report: cliff notes (CDC FluView) Influenza Vaccine Composition for the 2025-2026 U.S. Influenza Season (FDA) RSV: Waste water scan for 11 pathogens (WastewaterSCan) Respiratory Diseases (Yale School of Public Health) RSV-Network (CDC Respiratory Syncytial virus Infection) Vaccines for Adults (CDC: Respiratory Syncytial Virus Infection (RSV)) Economic Analysis of Protein Subunit and mRNA RSV Vaccination in Adults aged 50-59 Years (CDC: ACIP) Nirsevimab vs RSVpreF Vaccine for Respiratory Syncytial Virus–Related Hospitalization in Newborns (JAMA) RSV Immunization Frequently Asked Questions(American Academy of Pediatrics) Waste water scan for 11 pathogens (WastewaterSCan) COVID-19 deaths (CDC) Respiratory Illnesses Data Channel (CDC: Respiratory Illnesses) COVID-19 national and regional trends (CDC) COVID-19 variant tracker (CDC) SARS-CoV-2 genomes galore (Nextstrain) Antigenic and Virological Characteristics of SARS-CoV-2 Variant BA.3.2, XFG, and NB.1.8.1 (bioRxiV) Where to get pemgarda (Pemgarda) EUAfor the pre-exposure prophylaxis of COVID-19 (INVIYD) Infusion center (Prime Fusions) CDC Quarantine guidelines (CDC) NIH COVID-19 treatment guidelines (NIH) Drug interaction checker (University of Liverpool) Help your eligible patients access PAXLOVID with the PAXCESS Patient Support Program (Pfizer Pro) UnderstandingCoverageOptions (PAXCESS) Infectious Disease Society guidelines for treatment and management (ID Society) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) What to do when sick with a respiratory virus (CDC) Managing healthcare staffing shortages (CDC) Anticoagulationguidelines (hematology.org) Daniel Griffin's evidence based medical practices for long COVID (OFID) Long COVID hotline (Columbia : Columbia University Irving Medical Center) The answers: Long COVID Reaching out to US house representative Letters read on TWiV 1284 Dr. Griffin's COVID treatment summary (pdf) Timestamps by Jolene Ramsey. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv Content in this podcast should not be construed as medical advice.

In today's explosive Hidden Killers breakdown, we examine the testimony that has completely reshaped the Donna Adelson trial — testimony not from police, not from experts, but from Donna's own children, whose words now carry some of the greatest weight in the courtroom. First, we turn to Wendi Adelson, whose strategy has the courtroom buzzing. While her brother Robert delivered blunt, precise answers, Wendi leaned heavily on one phrase: “I don't remember.”  Again. And again. And again. But is this selective memory a trauma response from years of family pressure, manipulation, and emotional control?  Or is it a carefully crafted shield — a strategic fog meant to protect herself, the family, and possibly Donna? Psychotherapist Shavaun Scott joins Tony Brueski to dissect Wendi's demeanor in real time, explaining how adult children of dominant or narcissistic parents often split — one breaking free and telling the truth, the other staying entangled in loyalty, denial, or fear. Jurors watch every pause. Every hesitation. Every dodge. And Shavaun breaks down exactly what those signals mean. Then we shift to Robert Adelson, whose testimony landed like a hammer. Clinical. Direct. Brutally honest. He described Donna's controlling tendencies, her intrusion into major life decisions, and her eerie lack of concern after Dan Markel's murder. His words were not defensive. They were revelatory. Defense Attorney Eric Faddis joins Tony to analyze how jurors absorb testimony when it comes straight from a defendant's own children — one distancing herself through “I don't remember,” the other stepping into the sunlight with uncomfortable truth. Is this character evidence — or is it motive crystallized? Are we watching a family fracture, or a family finally telling the truth about its own internal gravity? This isn't just testimony. This is the Adelson family dynamic cracked open in front of a jury — loyalty, fear, denial, resentment, and survival all colliding in real time. #DonnaAdelson #WendiAdelson #DanMarkel #AdelsonTrial #TrueCrime #CourtroomDrama #ShavaunScott #EricFaddis #FamilyDynamics #HiddenKillers Want to comment and watch this podcast as a video? Check out our YouTube Channel. https://www.youtube.com/@hiddenkillerspod Instagram https://www.instagram.com/hiddenkillerspod/ Facebook https://www.facebook.com/hiddenkillerspod/ Tik-Tok https://www.tiktok.com/@hiddenkillerspod X Twitter https://x.com/tonybpod Listen Ad-Free On Apple Podcasts Here: https://podcasts.apple.com/us/podcast/true-crime-today-premium-plus-ad-free-advance-episode/id1705422872

What if balance is a lie and self-care does not look anything like Instagram told you it would?  In this powerful and refreshingly honest episode of Whinypaluza, host Rebecca Greene sits down with writer, speaker, activist, and mom of eight Elisha Beach for a real conversation about motherhood, burnout, and why the idea of “having it all” is complete nonsense. Elisha shares the moments that broke her open, including a very public mommy meltdown, clinical burnout, and the pressure to put everyone else first. Together, Rebecca and Elisha unpack what self-care actually looks like in real life, how guilt sneaks in, why villages matter more than ever, and how moms can reclaim control without adding another impossible to-do list item. This is the episode every overwhelmed parent did not know they needed.Six Key Takeaways→ Balance is not real, and that is not your failureElisha explains why the idea of perfect balance sets moms up to feel like they are always falling short → Burnout does not mean weakness Clinical burnout is real and often comes from prioritizing everyone else for too long →Self-care must fit your season of life What works for one mom may not work for another, and that is exactly the point → Guilt can exist without running the show You can feel guilt without letting it dictate how you treat yourself → Your village is bigger than you think Support can include people, systems, services, and small choices that reduce mental load → You are the expert in your own life. Trusting yourself is the most important form of self-care there isMemorable Quote“Balance does not exist. You just choose what you are going to focus on and let the rest fall off for a bit.”About the GuestElisha Beach is an experienced speaker, writer, and professional mom of eight. She went viral in 2015 after sharing a raw photo of breastfeeding her daughter while on the toilet and has been unapologetically telling the truth about motherhood ever since. A former staff writer for Scary Mommy and founder of The Mom Forum, Elisha is a Certified Strategic Planner who helps moms create realistic self-care practices without guilt. She is the author of The Mom Selfcare Planner and the upcoming book Balance Is Bullsht The Truth About Motherhood and Self Care* releasing November 11, 2025. If this episode made you feel seen, heard, or even a little less alone, share it with another parent who needs permission to stop chasing perfection. Subscribe, leave a review, and remember what Rebecca reminds us every day. Laugh. Learn. Love. Learn more about your ad choices. Visit megaphone.fm/adchoices

In today's explosive Hidden Killers breakdown, we examine the testimony that has completely reshaped the Donna Adelson trial — testimony not from police, not from experts, but from Donna's own children, whose words now carry some of the greatest weight in the courtroom. First, we turn to Wendi Adelson, whose strategy has the courtroom buzzing. While her brother Robert delivered blunt, precise answers, Wendi leaned heavily on one phrase: “I don't remember.”  Again. And again. And again. But is this selective memory a trauma response from years of family pressure, manipulation, and emotional control?  Or is it a carefully crafted shield — a strategic fog meant to protect herself, the family, and possibly Donna? Psychotherapist Shavaun Scott joins Tony Brueski to dissect Wendi's demeanor in real time, explaining how adult children of dominant or narcissistic parents often split — one breaking free and telling the truth, the other staying entangled in loyalty, denial, or fear. Jurors watch every pause. Every hesitation. Every dodge. And Shavaun breaks down exactly what those signals mean. Then we shift to Robert Adelson, whose testimony landed like a hammer. Clinical. Direct. Brutally honest. He described Donna's controlling tendencies, her intrusion into major life decisions, and her eerie lack of concern after Dan Markel's murder. His words were not defensive. They were revelatory. Defense Attorney Eric Faddis joins Tony to analyze how jurors absorb testimony when it comes straight from a defendant's own children — one distancing herself through “I don't remember,” the other stepping into the sunlight with uncomfortable truth. Is this character evidence — or is it motive crystallized? Are we watching a family fracture, or a family finally telling the truth about its own internal gravity? This isn't just testimony. This is the Adelson family dynamic cracked open in front of a jury — loyalty, fear, denial, resentment, and survival all colliding in real time. #DonnaAdelson #WendiAdelson #DanMarkel #AdelsonTrial #TrueCrime #CourtroomDrama #ShavaunScott #EricFaddis #FamilyDynamics #HiddenKillers Want to comment and watch this podcast as a video? Check out our YouTube Channel. https://www.youtube.com/@hiddenkillerspod Instagram https://www.instagram.com/hiddenkillerspod/ Facebook https://www.facebook.com/hiddenkillerspod/ Tik-Tok https://www.tiktok.com/@hiddenkillerspod X Twitter https://x.com/tonybpod Listen Ad-Free On Apple Podcasts Here: https://podcasts.apple.com/us/podcast/true-crime-today-premium-plus-ad-free-advance-episode/id1705422872

Clinical challenges and EMS games are powerful learning tools that blend vulnerability, courage, and joy. In this episode, recorded live at the 2025 New York State Vital Signs conference, Prodigy Medical Director Maia Dorsett and Prodigy Director of Critical Care Shane O'Donnell speak with the organizers behind the NY Vital Signs EMS Games to explore why simulation-based competition matters for learners and educators.  Listen in to hear how these competitions create psychologically safe spaces for growth, translate conference learning into real-world decision-making, and push clinical reasoning far beyond checklists. We unpack how thoughtful scenario design, intentional debriefing, and educator humility turn stress into deep learning. Mastery in EMS can come from this curiosity, reflection, and a willingness to step into discomfort. Ginger Locke highlights the episode's key points with her "Mindset Minute." The EMS Educator is published on the first Friday of every month! Be sure to turn on your notifications so you can listen as soon as the episode drops, and like/follow us on your favorite platform. Check out the Prodigy EMS Bounty Program! Earn $1000 for your best talks! Get your CE at www.prodigyems.com. Follow @ProdigyEMS on FB, YouTube, TikTok & IG.

Dr. Carolyn Dean is a powerhouse in the field of natural and integrative medicine. With dual degrees as a medical doctor and a naturopathic doctor, Dr. Dean's unique perspective and passions have made her a pioneering voice in natural health. While she's renowned for her groundbreaking work in magnesium therapy, mineral balance, and her critique of medicine's overreliance on pharmaceuticals, that doesn't even do justice to the breadth of her expertise. Dr. Dean has written over 30 books on topics ranging from hormonal health to yeast overgrowth.   Key Takeaways To Tune In For: (02:26) – Dr. Dean's Magnesium Journey (07:15) – Magnesium's Role in the Body (12:40) – Magnesium Absorption and Testing (20:21) – Clinical vs. Lab Testing (25:07) – The Importance of Basic Nutrients (31:04) – Minerals, Toxins, and Ultra-Processed Foods   Resources talked about in this episode: Website:  http://www.drcarolyndean.com http://www.rnareset.com   Social media handles: Instagram: @drcarolyndean  YouTube: @drcarolyndean  

Ring in the New Year with a fresh episode!Join Debora, Mark, and Noah in the latest Clinical Unknown Series as they unravel a puzzling case together.Let's start the year learning! To join us live on Virtual Morning Report (VMR), sign up HERE.Download CPSolvers App hereRLRCPSOLVERS

ReferencesCell. 2018 May 31;173(6):1356-1369.e22. Clinical and Molecular Teratology 2016. Volume 106, Issue 9 September Pages 749–760Biology (Basel). 2023 Mar 30;12(4):527. dInt J Mol Sci. 2021 Feb 22;22(4):2158. Anderson and Squire. 1971. I've Seen all Good People. Yes.https://music.youtube.com/watch?v=WfgPEh2J9aI&si=cTVabGFH5JYqN-EjMozart , WA. 1788. Symphony 40 in G Minor K550.https://music.youtube.com/watch?v=z_4jMxbwmVc&si=0n5dbpCqtE4WjYFw

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into some fascinating updates that are shaping the future of medicine and healthcare.Let's start with a groundbreaking development in cancer treatment. Researchers have announced significant progress in a novel therapy targeting a specific mutation often found in non-small cell lung cancer. This mutation, known as EGFR exon 20 insertion, has historically been resistant to standard treatments. The new therapy employs a targeted approach that precisely inhibits the mutant protein while sparing normal cells. Early-phase clinical trials have shown promising results, with substantial tumor shrinkage observed in participants. This could potentially redefine treatment protocols for patients who previously had limited options and improve their overall survival rates. As the study progresses into later phases, the industry is watching closely to see if these initial successes translate into long-term benefits.In another significant development, we're seeing advancements in gene therapy for inherited retinal diseases. A recent study has highlighted a novel gene-editing technique that promises to restore vision in patients with certain genetic forms of blindness. By utilizing CRISPR-Cas9 technology, scientists have been able to directly correct mutations in retinal cells. The preclinical models have shown restored function and improved visual responses, paving the way for human trials. This breakthrough is not just a beacon of hope for those affected by genetic blindness but also underscores the transformative potential of gene-editing technologies in treating complex diseases.Moving on to regulatory news, there's an update on new drug approvals that could have widespread implications for public health. The FDA has recently approved a first-in-class drug for the treatment of severe migraines. This medication represents a novel mechanism of action by targeting the calcitonin gene-related peptide (CGRP) pathway, which plays a crucial role in migraine pathophysiology. Clinical trials indicated that it significantly reduces the frequency and severity of migraine attacks compared to existing treatments. For millions of sufferers worldwide, this approval offers a new avenue for relief and highlights the importance of continued innovation in chronic pain management.Shifting gears to vaccine development, there's exciting progress in the fight against infectious diseases. A new vaccine candidate for malaria has shown an unprecedented level of efficacy in trial settings. This vaccine utilizes a protein-based approach that targets multiple stages of the parasite's lifecycle, thereby enhancing its protective effects. Given malaria's devastating impact globally, particularly in sub-Saharan Africa, this development is being hailed as a potential game-changer in global health efforts. As further studies and real-world evaluations unfold, this vaccine could become a cornerstone tool in reducing malaria's burden.Now turning our attention to industry trends, there's growing momentum around personalized medicine and its integration into mainstream healthcare systems. Personalized medicine tailors treatment strategies to individual patient profiles based on genetic, environmental, and lifestyle factors. Recent advances in genomics and data analytics have accelerated this shift, allowing for more precise and effective interventions. For healthcare providers and pharmaceutical companies alike, this trend necessitates rethinking traditional drug development models and embracing collaborative approaches to harness big data effectively.Finally, let's look at an intriguing development in neurodegenerative disease research. Scientists are exploring a new class of drugs designed to target protein misfolding—an underlying cause of conditions Support the show

Listen in as our expert panel discusses evidence-based approaches to help patients quit smoking, vaping, and using other nicotine products. You'll gain practical insights on medication selection, combination strategies, and tailored approaches for helping patients break free from nicotine addiction.Special guest:Robin Corelli, PharmD, CTTS, FCSHPProfessor of Clinical PharmacySchool of PharmacyUniversity of California, San FranciscoYou'll also hear practical advice from panelists on TRC's Editorial Advisory Board:Stephen Carek, MD, CAQSM, DipABLMClinical Associate Professor of Family MedicinePrisma Health/USC-SOMG Family Medicine Residency ProgramUSC School of Medicine GreenvilleCraig D. Williams, PharmD, FNLA, BCPSClinical Professor of Pharmacy PracticeOregon Health and Science UniversityNone of the speakers have anything to disclose. This podcast is an excerpt from one of TRC's monthly live CE webinars, the full webinar originally aired in November 2025.TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist's Letter, Pharmacy Technician's Letter,or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.Claim CreditThe clinical resources related to this podcast are part of a subscription to Pharmacist's Letter, Pharmacy Technician's Letter, and Prescriber Insights: Chart: Smoking Cessation Drug TherapyFAQ: E-Cigarettes and VapingChart: Dos and Don'ts With PatchesArticle: Help Patients Send Their Vaping Habits Up in Smoke Use code mt1026 at checkout for 10% off a new or upgraded subscription.Send us a textEmail us: ContactUs@trchealthcare.com. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Find the show on YouTube by searching for ‘TRC Healthcare' or clicking here. Learn more about our product offerings at trchealthcare.com.

About 24.2% of U.S. men today screen positive for erectile dysfunction (ED), while global rates range from 3% to 76.5%, showing it's a common health problem that affects men of all ages A 2025 study in the American Journal of Clinical and Experimental Urology found that ED is influenced by genes that also raise risk for obesity, diabetes, heart disease, and addiction, tying erection problems to long-term heart health ED is usually multifactorial, with vascular, neurogenic, hormonal, and psychogenic forms, and is strongly associated with conditions like heart disease, obesity, sleep apnea, and depression, making it a powerful early warning sign that something deeper is wrong While drugs like Viagra can temporarily improve erections, they don't work for everyone and may be unsafe for men taking heart and lung medications Instead of relying solely on pills, addressing root causes with a heart-focused check-up, a metabolic-friendly diet, pelvic floor training, restorative sleep, enough sunlight and mindful supplementation can help restore sexual function without more drugs

Daily Border Crossings partnered with The Siena School for this special edition episode on Transracial Adoption: A Conversation about Parenthood and Family when Love Race and Identity Intersect where panelists give relevant, thoughtful, necessary tips and pointers for navigating successfully across cultures and difference.Host Samantha Fletcher has an insightful, must-hear conversation with esteemed panelists Beverly Clarke and Christopher Brown on transracial adoption and how the experiences and needs are not unlike other adoptive families in many ways…and also are unique in certain ways. Guests explore complexities via first person lived experience and professional expertise. Our panelists will discuss the opportunities and challenges of raising and supporting children across racial and cultural lines, supporting parents and offering insight for educators and community members seeking to foster inclusive and affirming environments. Panelists are:Beverly Clarke, a former Siena parent, currently serves as the Senior Director of Clinical & Support Services at The Barker Adoption Foundation.  In her role with Barker, Bev is responsible for managing, developing, implementing, and providing oversight and quality assurance for the clinical aspects of the work provided by the agency's adoption and support programs. Christopher Brown is the Dean of Equity and Belonging at Brewster Academy in New Hampshire; prior to Brewster, Christopher worked as an Academic Support teacher, Diversity Coordinator, coach, and advisor. He is a transracial adoptee, having been adopted by white parents, and he shares his story to impact the narrative on transracial adoption.Find Daily Border Crossings podcast at:Apple: https://podcasts.apple.com/us/podcast/daily-border-crossings/id1517113315YouTube: https://www.youtube.com/@dailybordercrossingspodcas3258Spotify: https://open.spotify.com/show/2U9ZjlsMZiE2dnRrdlP1BG Reach Samantha Fletcher at dailybordercrossings@gmail.com www.SamanthaFletcher.com

Purely Clinical is more than an event; it's an experience where education meets innovation and the future of skincare takes shape.Over the past year, the Lira Clinical owners traveled across the globe delivering advanced education, protocol-driven learning, and exclusive first looks at upcoming innovations, straight to the treatment room. We're recapping standout moments from the tour stops and unpacking what attendees truly gained, from interactive sessions and protocol development to testing prototypes and influencing product launches before they hit the market.And of course, we're teasing what's ahead, because Purely Clinical 2026 is already shaping up to be something special. Join expert hosts and Lira Clinical founders Metaxia Dalikas and Francine Kagarakis for an inside look at the experience that's redefining clinical education.

Careful assessment and individualized care, provided by a skilled multidisciplinary care team, are emphasized in the holistic approach to neuropalliative care, which considers physical, psychological, social, spiritual, and existential aspects for people with neuromuscular diseases. In this episode, Gordon Smith, MD, FAAN, speaks with David J. Oliver, PhD, FRCP, FRCGP, FEAN, author of the article "Neuropalliative Care in Neuromuscular Disorders" in the Continuum® December 2025 Neuropalliative Care issue. Dr. Smith is a Continuum® Audio interviewer and a professor and chair of neurology at Kenneth and Dianne Wright Distinguished Chair in Clinical and Translational Research at Virginia Commonwealth University in Richmond, Virginia. Dr. Oliver is an honorary professor of Tizard Centre at the University of Kent in Canterbury, United Kingdom. Additional Resources Read the article: Neuropalliative Care in Neuromuscular Disorders Subscribe to Continuum®: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Host: @gordonsmithMD Full episode transcript available here Dr Jones: This is Dr Lyell Jones, Editor-in-Chief of Continuum. Thank you for listening to Continuum Audio. Be sure to visit the links in the episode notes for information about earning CME, subscribing to the journal, and exclusive access to interviews not featured on the podcast. Dr Smith: Hello, this is Dr Gordon Smith. Today I've got the great pleasure of interviewing Dr David Oliver about his article on neuropalliative care and neuromuscular disorders, which appears in the December 2025 Continuum issue on neuropalliative care. David, welcome to the Continuum podcast, and please introduce yourself to our audience. Dr Oliver: Thank you. It's a pleasure and a privilege to be here. I'm a retired consultant in palliative medicine in the UK. I worked at the Wisdom Hospice in Rochester for over thirty years, and I'm also an honorary professor at the University of Kent in Canterbury in the UK. I've had a long interest in palliative care in neurological diseases. Hopefully we can talk about a bit later. Dr Smith: I really look forward to learning a little bit more about your path and experiences. But I wonder if, before we get into the meat of neuropalliative care with a focus on neuromuscular, if maybe you can kind of set the stage by just defining palliative care. I mean, my experience is that people think of this in different ways, and a lot of folks think- hear palliative care, and they immediately go to end-of-life care or comfort care. So, what- how should we think about maybe the discipline of palliative care or neuropalliative care? Dr Oliver: I see palliative care as very much responding to people's needs, whether that's physical needs, psychological needs, social or spiritual or existential. So, it can be much earlier in the disease progression. And I think particularly for neurological diseases, early involvement may be very important. Dr Smith: That was actually going to be my first substantive question, really, was when to begin the conversation and what does that look like and how does it evolve over time. You have a really great figure in the article that kind of emphasizes the various stages within a patient's journey that, you know, palliative care can become involved. But I wonder if you could use ALS as a good example and describe what that looks like from when a patient is first diagnosed with ALS through their course? Dr Oliver: I think particularly in ALS at the beginning, soon after diagnosis, someone may have a lot of distress and a lot of questions that they need answering. This is a disease they've not had any contact with before. And they don't understand what's going on, they don't understand the disease. So, there may be a great need to have the opportunity to talk about the disease, what may happen, what is happening, how it's going to affect them and their family. As think time goes on, there may be later they develop swallowing problems, and that will need to be talking about a feeding tube and gastrostomy. And again, there may be a lot of issues for the person and their family. As they deteriorate, they may have respiratory problems and need to have discussion about ventilatory support, either by PAP, noninvasive ventilation, or even tracheostomy. And again, I think that's a big issue that needs wide discussion. And then it may be at the final few months of the disease, where they are deteriorating, that they may have increased needs, and their families may have those needs after the death. And I think often families bereaved from someone with a neurological disease such as ALS need a great deal of support, having many mixed emotions. There may be a feeling of relief that they're not involved in that caring, but then a feeling of guilt that they shouldn't be having those feelings. So, I think that can happen over a period of… what with ALS it may be two, three, four years, but it may be similar changes over time with any patient with a neurological disease. It may be ten or fifteen years with Parkinson's or five to ten years with a progressive supranuclear palsy, but there'll be this similar need to look at palliative care during their disease progression. Dr Smith: So, I'm curious at the time of diagnosis of ALS, how far out in the future do you provide information? So a specific question would be, do you talk about end-of-life management? In my experience, ALS patients are sometimes interested in knowing about that. Or do you really focus on what's in front of you in the next three to six months, for instance? Dr Oliver: I think it's both. Obviously, we need to talk about the next three to six months, but often giving patients the opportunity to talk about what's going to happen in the future, what may happen at the end of life, I think is important. And I think a disease like ALS, if they look it up on the Internet, they may have a lot of very distressing entries there. There's a lot about how distressing dying with ALS is. And actually confront those and discuss those issues early is really important. Dr Smith: So of course, the other thing that comes up immediately with an ALS diagnosis---or, for that matter, with any other neurodegenerative problem---is prognosis. Do you have guidance and how our listeners who are giving a diagnosis of ALS or similar disorder should approach the prognostication discussion? Dr Oliver: It's often very difficult. Certainly in the UK, people may have- be a year into their disease from their first symptoms before they're diagnosed, and I've seen figures, that's similar across the world. So, people may be actually quite way through their disease progression, but I do think we have to remember that the figures show that at five years, 25% of people are still alive, and 5 to 10% are still alive at ten years. We mustn't say you are going to die in the next two or three years, because that may not be so. And I think to have the vagueness but also the opportunity to talk, that we are talking of a deterioration over time and we don't know how that will be for you. I always stress how individual I think ALS is for patients. Dr Smith: One of the other concepts that is familiar with anyone who does ALS and clearly comes through in your article---which is really outstanding, by the way. So, thank you and congratulations for that---is the importance of multidisciplinary teams. Can you talk a little bit about how neuropalliative care sits within a multidisciplinary care model? Dr Oliver: I think the care should be multidisciplinary. Certainly in the UK, we recommended multidisciplinary team care for ALS in particular, from the time of diagnosis. And I think palliative care should be part of that multidisciplinary team. It may be a member of the team who has that palliative care experience or someone with specialist experience. Because I think the important thing is that everyone caring for someone with ALS or other neuromuscular diseases should be providing palliative care to some extent: listening to people, discussing their goals, managing their symptoms. And a specialist may only be needed if those are more complicated or particularly difficult. So, I think it is that the team needs to work together to support people and their families. So, looking at the physical aspects where the physiotherapist or occupational therapist may be very important, the psychologicals are a counsellor or psychologist. The social aspects, most of our patients are part of wider families, and we need to be looking at supporting their carers and within their family as well as the person. And so that may involve social work and other professionals. And the spiritual, the why me, their fears about the future, may involve a spiritual counsellor or a chaplain or, if appropriate, a religious leader appropriate to that- for that person. So, I think it is that wider care provided by the team. Dr Smith: I'm just reflecting on, again, your earlier answers about the Continuum of neuropalliative care. Knowing your patient is super valuable here. So, having come to know someone through their disease course must pay dividends as you get to some of these harder questions that come up later during the disease progression. Dr Oliver: I think that's the very important use of palliative care from early on in the diagnosis. It's much easier to talk about, perhaps, the existential fears of someone while they can still talk openly. To do that through a communication aid can be very difficult. To talk about someone's fear of death through a communication aid is really very, very difficult. The multidisciplinary team, I think, works well if all the members are talking together. So that perhaps the speech therapist has been to see someone and has noticed their breathing is more difficult, comes back and talks to the doctor and the physiotherapist. The social worker notices the speech is more difficult and comes back and speaks to the speech therapist. So, I think that sort of team where people are working very closely together can really optimize the care. And as you said, knowing the person, and for them to know you and to trust you, I think that's important. Those first times that people meet is so important in establishing trust. And if you only meet people when they're very disabled and perhaps not able to communicate very easily, that's really difficult. Dr Smith: I think you're reading my mind, actually, because I was really interested in talking about communication. And you mentioned a few times in your article about voice banking, which is likely to be a new concept for many of our listeners. And I would imagine the spectrum of tools that are becoming available for augmented communication for patients who have ALS or other disorders that impair speech must be impressive. I wonder if you could give us an update on what the state of the art is in terms of approaching communication. Dr Oliver: Well, I think we all remember Stephen Hawking, the professor from Cambridge, who had a very robotic voice which wasn't his. Now people may have their own voice on a communication aid. I think the use of whether it's a mobile phone or iPad, other computer systems, can actually turn what someone types into their own voice. And voice banking is much easier than it used to be. Only a few years ago, someone would have to read for an hour or two hours so the computer could pick up all the different aspects of their voice. Now it's a few minutes. And it has been even- I've known that people have taken their answer phone off a telephone and used that to produce a voice that is very, very near to the person. So that when someone does type out, the voice that comes out will be very similar to their own. I remember one video of someone who'd done this and they called their dog, and the dog just jumped into the air when he suddenly heard his master's voice for the first time in several months. So, I think it's very dramatic and very helpful for the person, who no longer feels a robot, but also for their family that can recognize their father, their husband, their wife's speech again. Dr Smith: Very humanizing, isn't it? Dr Oliver: There is a stigma of having the robotic voice. And if we can remove that stigma and someone can feel more normal, that would be our aim. Dr Smith: As you've alluded to, and for the large majority---really all of our ALS patients, barring something unexpected---we end up in preparing for death and preparing for end of life. I wonder what advice you have in that process, managing fear of death and working with our patients as they approach the end of their journey. Dr Oliver: I think the most important thing is listening and trying to find what their particular concerns are. And as I said earlier, they may have understood from what they've read in books or the Internet that the death from ALS is very distressing. However, I think we can say there are several studies now from various countries where people have looked at what happens at the end of life for people with ALS. Choking to death, being very distressed, are very, very rare if the symptoms are managed effectively beforehand, preparations are made so that perhaps medication can be given quickly if someone does develop some distress so that it doesn't become a distressing crisis. So, I think we can say that distress at the end of life with ALS is unusual, and probably no different to any other disease group. It's important to make sure that people realize that with good symptom control, with good palliative care, there is a very small risk of choking or of great distress at the end of life. Dr Smith: Now, I would imagine many patients have multiple different types of fear of death; one, process, what's the pain and experience going to be like? But there's also being dead, you know, fear of the end of life. And then this gets into comments you made earlier about spirituality and psychology. How do you- what's your experience in handling that? Because that's a harder problem, it seems, to really provide concrete advice about. Dr Oliver: Yeah. And so, I think it's always important to know when someone says they're frightened of the future, to check whether it is the dying process or after death. I've got no answer for what's going to happen afterwards, but I can listen to what someone may have in their past, their concerns, their experience. You know, is their experience of someone dying their memories of someone screaming in pain in an upstairs bedroom while they were a child? Was their grandfather died? Trying to find out what particular things may be really a problem to them and that we can try and address. But others, we can't answer what's going to happen after death. If someone is particularly wanting to look at that, I think that may be involving a spiritual advisor or their local spiritual/religious leader. But often I think it's just listening and understanding where they are. Dr Smith: So, you brought up bereavement earlier and you discussed it in the article. In my experience is that oftentimes the families are very, very impacted by the journey of ALS. And while ALS patients are remarkably resilient, it's a huge burden on family, loved ones, and their community. Can you talk a bit about the role of palliative care in the bereavement process, maybe preparing for bereavement and then after the loss of their loved one? Dr Oliver: Throughout the disease progression, we need to be supporting the carers as much as we are the patient. They are very much involved. As you said, the burden of care may be quite profound and very difficult for them. So, it's listening, supporting them, finding out what their particular concerns are. Are they frightened about what's going to happen at the end of life as well? Are they concerned of how they're going to cope or how the person's going to cope? And then after the death, it's allowing them to talk about what's happened and how they are feeling now, cause I think having had that enormous input in care, then suddenly everything stops. And also, the support systems they've had for perhaps months of the carers coming in, the doctor, the nurse, the physiotherapist, everyone coming in, they all stop coming. So, their whole social system suddenly stops and becomes much reduced. And I'm afraid certainly in the UK if someone is bereaved, they may not have the contact with their friends and family because they're afraid to come and see them. So, they may become quite isolated and reduced in what they can do. So, I think it's allowing them to discuss what has happened. And I think that's as important sometimes for members of the multidisciplinary team, because we as doctors, nurses and the wider team will also have some aspects of bereavement as we face not seeing that person who we've looked after for many years and perhaps in quite an intensive way. So, we need to be looking at how we support ourselves. And I think that's another important role of the multidisciplinary team. I always remember in our team, sometimes I would say, I find this person really difficult to cope with. And the rest of the people around the team would go have a sigh of relief because they felt the same, but they didn't like to say. And once we could talk about it, we could support each other and work out what we could do to help us help the patient in the most effective way. Dr Smith: Well, David, I think that's a great point to end on. I think you've done a really great job of capturing why someone would want to be a palliative care specialist or be involved in palliative care, because one of the themes throughout this conversation is the very significant personal and care impact that you have on patients and families. So, I really appreciate your sharing your wisdom. I really encourage all of our listeners to check out the article, it's really outstanding. I wonder if maybe you might just briefly tell us a little bit about how you got into this space? It's obviously one for which you have a great deal of passion and wisdom. How did you end up where you are? Dr Oliver: I became interested in palliative care as a medical student, and actually I trained as a family doctor, but I went to Saint Christopher's Hospice following that. I had actually had contact with them while I was a medical student, so I worked Saint Christopher's Hospice in South London when Dame Cecily Saunders was still working there. And at that time Christopher's had sixty-two beds, and at least eight of those beds were reserved for people with ALS or other neurological diseases. And I became very involved in one or two patients and their care. And Dame Sicily Saunders asked me to write something on ALS for their bookshelf that they had on the education area. So, I wrote, I think, four drafts. I went from sort of C minus to just about passable on the fourth draft. And that became my big interest in particularly ALS, and as time went on, in other neurological diseases. When I went to the Wisdom Hospice as a consultant, I was very keen to carry on looking after people with ALS, and we involved ourselves with other neurological patients. That's how I got started. Having that interest, listening to patients, documenting what we did became important as a way of showing how palliative care could have a big role in neurological disease. And over the years, I've been pressing again and again for the early involvement of palliative care in neurological diseases. And I think that is so important so that there can be a proper holistic assessment of people, that they can build up the trust in their carers and in the multidisciplinary team so that they can live as positively as possible. And as a result of that, that their death will be without distress and with their family with them. Dr Smith: Well, David, you've convinced and inspired me, and I'm confident you have our listeners as well. Thank you so much for a really informative, enjoyable, inspiring conversation. Dr Oliver: Thank you for inviting me. Dr Smith: Again, today I've been interviewing Dr David Oliver about his article on neuropalliative care and neuromuscular disorders, which appears in the December 2025 Continuum issue on neuropalliative care. Be sure to check out Continuum Audio episodes from this and other issues, and thanks to our listeners for joining us today. Dr Monteith: This is Dr Teshamae Monteith, Associate Editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information important for neurology practitioners. Use the link in the episode notes to learn more and subscribe. AAN members, you can get CME for listening to this interview by completing the evaluation at continpub.com/audioCME. Thank you for listening to Continuum Audio.

It's New Year's Eve Eve! Zach and Kevin return to close out the year with returning guests Dr. Gary Holtzclaw and Dr. Erin Elliott. In this final episode of 2025, the crew trades stories about their most memorable (and traumatic) New Year's Eve experiences—including a high school snowball fight that went terribly wrong and an intense dental school dodgeball tournament. Later, the conversation shifts from parties to protocols as the group discusses the major clinical and business changes they implemented in their practices this year. From AI integration and staffing shake-ups to battles with corporate CEOs and the rise of "Google Review extortion," they cover the highs and lows of practicing dentistry in 2025. Join the Very Clinical Facebook group!  Join the Very Dental Facebook Group using one of these passwords: Timmerman, Bioclear, Hornbrook, Gary, McWethy, Papa Randy, or Lipscomb!  The Very Dental Podcast network is and will remain free to download. If you'd like to support the shows you love at Very Dental then show a little love to the people that support us! I'm a big fan of the Bioclear Method! I think you should give it a try and I've got a great offer to help you get on board! Use the exclusive Very Dental Podcast code VERYDENTAL8TON for 15% OFF your total Bioclear purchase, including Core Anterior and Posterior Four day courses, Black Triangle Certification, and all Bioclear products. Crazy Dental has everything you need from cotton rolls to equipment and everything in between and the best prices you'll find anywhere! If you head over to verydentalpodcast.com/crazy and use coupon code "VERYSHIP" you'll get free shipping on your order! Go save yourself some money and support the show all at the same time! The Wonderist Agency is basically a one stop shop for marketing your practice and your brand. From logo redesign to a full service marketing plan, the folks at Wonderist have you covered! Go check them out at verydentalpodcast.com/wonderist! Enova Illumination makes the very best in loupes and headlights, including their new ergonomic angled prism loupes! They also distribute loupe mounted cameras and even the amazing line of Zumax microscopes! If you want to help out the podcast while upping your magnification and headlight game, you need to head over to verydentalpodcast.com/enova to see their whole line of products! CAD-Ray offers the best service on a wide variety of digital scanners, printers, mills and even  their very own browser based design software, Clinux! CAD-Ray has been a huge supporter of the Very Dental Podcast Network and I can tell you that you'll get no better service on everything digital dentistry than the folks from CAD-Ray. Go check them out at verydentalpodcast.com/CADRay!

JAMA Deputy Editor Mary McDermott, MD, and JAMA Deputy Editor Kristin Walter, MD, MS, highlight their selections of top JAMA Clinical Reviews podcasts in 2025. Related Content: Managing Adverse Effects of Obesity Medications Diagnosis and Management of Hypothyroidism Type 2 Diabetes: Diagnosis and Current Guidelines for Treatment Managing Adverse Effects of Incretin-Based Medications for Obesity Hypothyroidism Diagnosis and Treatment of Type 2 Diabetes in Adults JAMA Editors' Choice 2024: Clinical Reviews Podcasts

This podcast is brought to you by Outcomes Rocket, your exclusive healthcare marketing agency. Learn how to accelerate your growth by going to⁠ outcomesrocket.com AI is finally eliminating the documentation burden that has slowed physicians for decades. In this episode, Dr. James Maisel, CEO and founder of ZyDoc, shares his three-decade journey from retina surgeon to health-tech entrepreneur and how AI is transforming clinical documentation. He reflects on early attempts to build electronic health records in the 1990s, the inefficiencies created by click-heavy systems, and why dictation consistently outperformed keyboard-based workflows. Dr. Maisel explains how advances in speech recognition and generative AI now make real-time, structured clinical notes possible, seamlessly integrating into EHRs and significantly reducing physician workload. He also explores health literacy challenges, physician adoption, specialty-specific language models, and the future of AI-driven diagnostics, particularly in the context of eye imaging. Tune in and learn how AI is reshaping clinical documentation, physician efficiency, and the future of medical practice! Resources: Connect with and follow Dr. James Maisel on LinkedIn. Follow ZyDoc on LinkedIn and visit their website!

In this episode, Dan Hackner, MD, Chief Clinical and Academic Officer, Southcoast Health, joins the podcast to discuss the role of concurrent data in improving clinical decision-making. He addresses gaps in educating and supporting caregivers, how health systems can anticipate the future affordability of care, and why deeply understanding community needs is essential to driving meaningful innovation in healthcare.

Glioblastoma has a long-term survival rate under 1% at ten years. After decades of research focusing primarily on mutation-targeted therapies, median survival has improved by only a few months. Dr. Tomás Duraj believes there's a better path forward.Dr. Duraj is a physician-scientist at Boston College working on the metabolic vulnerabilities of cancer. In this Metabolic Health Summit presentation, he outlines a clinical framework for studying ketogenic metabolic therapy — one built on biomarker-driven protocols, not dietary guesswork.The core argument: cancer cells depend on specific metabolic pathways for survival. Block those pathways while providing alternative fuels to healthy cells, and you create a therapeutic window that most tumors can't escape.Why cancer cells metabolically resemble organisms from 2 billion years agoThe limits of the somatic mutation theory and why most targeted gene therapies have underdeliveredSubstrate level phosphorylation vs. oxidative phosphorylation — and why the distinction mattersThe Glucose-Ketone Index as a measurable, actionable biomarkerThe press-pulse strategy: sustained metabolic pressure paired with targeted interventionsHow to protect healthy tissue before targeting tumor metabolismRepurposed pharmacological approaches and the need for publicly funded clinical trialsThe case for small, non-randomized pilot studies with highly motivated patientsMetabolic therapy represents the future of medicine: a coherent clinical strategy grounded in decades of research and increasingly recognized by physicians and scientists across disciplines. For practitioners seeking complementary approaches that extend the reach of oncological therapeutics, this presentation lays out a practical roadmap for integrating emerging insights with standard care.✅Genova Connect – Get 15% off any test kit with code METABOLICLINK here.✅ iRestore - Get a huge discount on the iRestore Illumina Face Mask when you use the code METABOLICLINK here.✅Piquelife.com - Get the Pu'er Bundle for 20% off here.In every episode of The Metabolic Link, we'll uncover the very latest research on metabolic health and therapy. If you like this episode, please share it, subscribe, follow, and leave us a comment or review on whichever platform you use to tune in!You can find us on all your major podcast players here and full episodes are also up on our Metabolic Health Summit YouTube channel!Find us on social: Instagram Facebook YouTube LinkedIn Please keep in mind: The Metabolic Link does not provide medical or health advice, but rather general information that does not serve as a substitute for a licensed healthcare professional. Never delay in seeking medical advice from an appropriately licensed medical provider for any health condition that you may have.

In this episode, our guest is Mary V. Relling, Pharm.D. Emerita Member, Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN. Dr. Relling earned her undergraduate B.S. degree from the University of Arizona College of Pharmacy and her doctoral degree from the University of Utah College of Pharmacy. She completed post-doctoral fellowships with Dr. William Evans at St. Jude and with Dr. Urs Meyer at University of Basel. She joined St. Jude as a faculty member in 1988, and was chair ofthe Department of Pharmaceutical Sciences from 2003-2020. She was also a professor at the University of Tennessee in the Colleges of Medicine and Pharmacy. Her primary interests are in the treatment and pharmacogenetics of childhood leukemia and in the clinical implementation of pharmacogenetic testing in medicine. Dr. Relling is co-founder of CPIC, the Clinical Pharmacogenetics Implementation Consortium. She has published over 450 original scientific manuscripts. She was elected to the Institute of Medicine (National Academy of Medicine) in 2009.Topics to discuss:Foundations & Career JourneyYou've had an extraordinary career at St. Jude since joining in 1988. What first drew you to pediatric pharmacology and pharmacogenetics?Your work has helped shape how we treat childhood leukemia. What do you see as the most transformative advancements in this space over your career?Pharmacogenetics & CPICYou co-founded the Clinical Pharmacogenetics Implementation Consortium (CPIC). What was the impetus behind its creation, and how has its mission evolved?What do you see as the biggest barriers to widespread clinical implementation of pharmacogenetic testing today?How do you respond to skepticism about the clinical utility of pharmacogenetic testing in everyday medical practice?Which pharmacogenetic guidelines do you believe have had the most significant clinical impact so far—and why?What advice do you have for institutions that want to start implementing pharmacogenetic testing but don't know where to begin?Implementation in Clinical SettingsAt St. Jude, you helped lead efforts to integrate pharmacogenetic testing into clinical care. What lessons did you learn about operationalizing this work in real-world settings?How important is interdisciplinary collaboration—between pharmacists, physicians, geneticists—in making pharmacogenetic testing work in practice?Can you share an example where pharmacogenetic testing changed the course of treatment for a pediatric patient?Policy, Ethics, and Future VisionWhat policy or regulatory changes would help accelerate the clinical adoption of pharmacogenetic testing?As someone who has contributed extensively to the science, how do you think we should balance data privacy with the need for clinical data sharing in genomics?What are you most excited about in the future of pharmacogenetics? Are there particular therapeutic areas or technologies that you think will drive the next wave of innovation?Legacy & AdviceYou've mentored many rising leaders in the field. What qualities do you think are most important for the next generation of pharmacogenomics researchers and clinicians?With over 450 publications and a career that has changed pediatric pharmacology, what legacy do you hope your work leaves behind?Guest: Mary V. Relling, Pharm.D. Emerita Member, Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research HospitalHost: Hillary Blackburn, PharmD, MBAwww.hillaryblackburn.comhttps://www.linkedin.com/in/hillary-blackburn-67a92421/  ★ Support this podcast on Patreon ★

In this episode of the Science of Skin podcast, Dr. Ted Lain and Dr. Andrew Alexis discuss Triferatine Cream, a novel fourth-generation retinoid. They explore its mechanism of action, clinical efficacy, and the importance of addressing not only acne lesions but also the psychosocial impacts of acne on patients. The conversation delves into the results of phase three and phase four clinical trials, highlighting Triferatine's effectiveness in treating both acne and post-inflammatory hyperpigmentation. The episode emphasizes the need for dermatologists to consider the entire acne journey and the long-term benefits of retinoid therapy for their patients. To watch this an other episodes, be sure to check out our YouTube page Takeaways: Triferatine is a novel fourth-generation retinoid. It binds preferentially to the RAR gamma receptor, enhancing its efficacy. Triferatine not only treats acne but also improves scarring and pigmentation. Clinical trials show significant efficacy in both facial and truncal acne. The psychosocial impact of acne is profound and long-lasting. Retinoids are foundational in acne treatment regimens. Patients benefit from continued use of retinoids beyond acne clearance. Phase four studies demonstrate Triferatine's effectiveness in reducing atrophic scars. Acne-induced hyperpigmentation is a significant concern that needs addressing. Education about retinoids can improve patient compliance.See omnystudio.com/listener for privacy information.

Dr. Timothy Spurrell—a fan favorite from Episode 7—is back for a powerful conversation on what truly sets great clinical leaders apart. In this episode, he shares practical insights, real-world lessons, and leadership perspectives that resonate with clinicians and executives alike.If you're looking for grounded wisdom, candor, and inspiration you can actually use in your healthcare environment, this is one episode you won't want to miss. Dr. Spurrell unpacks what great clinical leaders consistently do (and what they avoid), how strong leadership shows up in chaos and change, and the habits that build trust, accountability, and alignment across teams. You'll also hear practical ways to communicate with clarity and empathy—without lowering standards—and a refreshing reminder that great leadership isn't about charisma; it's about consistency.✨ Stay tuned for Part Two:  The Backbone, not the Face. It releases January 21, 2026 (you'll want the follow-up!)Guest: Dr. Timothy SpurrellHost: Amanda Laramie Book shoutouts in this episode:Will Guidara: Unreasonable Hospitality Thanks for listening! If you or someone you know should be interviewed for this show, send us an email. Check us out on: FacebookInstagramLinkedInOur WebsiteTikTokTwitterYouTube

Is science enough for total healing? Dr. Alex Lion and Dr. Anastasia Holman reveal how Spiritual Care in Healthcare is the secret to supporting clinical teams and patients in crisis. Modern medicine often focuses on the cure, but what happens when the goal is healing the whole person? In this episode of The Chaplain's Compass, hosts Rev. Alice Tremaine and Rev. John Betz explore the "Team-Based Spirituality" model. This revolutionary curriculum moves spiritual care out of the silo of the chaplaincy and integrates it into the daily workflow of physicians, nurses, and interprofessional teams. By analyzing the Havruta method of collaborative reflection and sharing case studies from pediatric neuro-oncology, our guests prove that spiritual care is a vital resource for preventing clinician burnout and navigating complex medical uncertainty. Whether you are a healthcare leader or a frontline provider, you will learn how to create inclusive spaces that honor every faith background—including atheism—to provide truly comprehensive care. Upcoming Workshop Meet the Speakers in New Orleans! Dr. Alex Lion and Reverend Dr. Anastasia Holman will be presenting a hands-on workshop on the Team-Based Spirituality Curriculum at the 2026 APC Conference. Don't miss this opportunity to learn how to scale spiritual care in your health system. Connect with Alice and John on social media: Instagram: @alicetremaine (Alice) @researchchaplain (John) https://www.linkedin.com/in/alicetremaine/ https://www.linkedin.com/in/chaplainbetz/ Leave us a message at the Chaplain's Compass phone number: 502-536-7508 Learn more about chaplaincy at https://www.chaplaincynow.com/ and the association of professional chaplains at https://www.apchaplains.org/

There's been a lot of focus lately on how much ‘screen time' children have and how technology is negatively impacting them. But scrolling on a cell phone all day is also terrible for adults. This is why many are making the case that both adults and children do a ‘digital detox' in 2026. Clinical psychologist and family therapist Dr. Sheryl Ziegler explains how damaging cell phones and social media have been for people of all ages, and offers tips on unplugging and improving mental health by avoiding the traps of modern tech. Then, we revisit one of our most impactful interviews from the past year, when Chairman of the House Intelligence Committee, Rep. Rick Crawford (AR-01) joined Mike Emanuel to react to President Trump's bold decision to bomb three Iranian nuclear sites this past June. Plus, commentary by Chuck DeVore, chief national initiatives officer with the Texas Public Policy Foundation. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Are you ready to feel grounded, energized, and confident in your wellness this year? Are you tired of starting January with restriction instead of nourishment? Do you want habits that actually stick and support your metabolism, hormones, and mental health? In this episode, Ali and Becki kick off the new year by sharing five foundational ways to invest in your wellness so your routines feel craveworthy, not forced. We discuss how pleasure, satisfaction, and real food are essential for sustainability, how to navigate cravings without shame, and why creating routines your body desires leads to lasting change. We also dive into supporting detox pathways, balancing blood sugar, and understanding how hormonal shifts—especially changes in estrogen—impact insulin sensitivity and metabolism as women age. Ali and Becki cover practical strategies for metabolic flexibility, the role of gratitude in nervous system and metabolic regulation, and why getting outside daily may be one of the most powerful (and overlooked) tools for stress resilience and healing.  Also in this episode:  Keto Reset Masterclass: 1/7/26 at 12pm CST  10-day Detox Masterclass: 1/5/26 at 12pm CST Keto Reset Program use code RESET75 Make your wellness craveworthy Super Greens Cubes FOND Bone Broth use code ALIMILLERRD Red Light Mask LumeBox Red Light use code BECKIYOO PEMF & Red Light Mat use code BeckiYoo10fs Addressing food cravings Naturally Nourished Episode 472 Good, Better, Best with Brenda … You Glow Girl Tea Support Your Detox Pathways E3 Live Beam Minerals Cellular Antiox Balance Your Blood Sugar The Role of Estrogen in Insulin Resistance: A Review of Clinical and Preclinical Data - ScienceDirect Naturally Nourished Episode 395 Testing Women's Hormones KetoMojo Nutrisense Practice Gratitude Naturally Nourished Episode 164 Make Positivity Louder and Keto … Work with Becki use code BECKIPACK for 10% off Get Outside Naturally Nourished Episode 424 How Daily Walking Can Transform … Naturally Nourished Episode 322 Nature as Medicine | Ali Miller RD Ali & Becki's Words for the Year Emerging Trends in the Wellness Space EMF Mitigation Aires Tech This episode is sponsored by the Naturally Nourished Food-as-Medicine Keto Reset. Our Keto Reset is a 12-week, real-food, functional medicine–based program designed to help you lower insulin, improve metabolic flexibility, and address the root causes behind stubborn weight loss, hormone imbalance, gut dysfunction, and chronic inflammation. Unlike traditional keto plans, this program focuses on macronutrient strategy over calorie obsession, antioxidant density, therapeutic foods, and high-quality sourcing—while eliminating ultra-processed foods and non-caloric sweeteners. The goal isn't restriction or perfection, but teaching your body how to burn fat efficiently while feeling nourished and supported. Throughout the program, you'll learn how to personalize your approach using sliding-scale protocols, understand how stress, hormones, and blood sugar influence metabolism, and build sustainable habits that lead to true food freedom. With weekly live classes, Q&As, and access to Ali and Becki's combined 20+ years of functional medicine experience, the Keto Reset is designed to work with your physiology—not against it—so you can finally feel confident, clear, and in control of your health. Join us now, use code RESET75 to save  

Send us a textAs 2025 comes to a close, Ben and Daphna reflect on a year of growth, community, and evolution for The Incubator Podcast. In this end-of-year wrap-up, they preview major changes coming in 2026, including new standalone podcast feeds, expanded journal club content, CME opportunities, and exciting partnerships with organizations like the Vermont Oxford Network and PAS. They also share what's ahead for the Delphi Conference and offer a candid look at their personal and professional goals for the year ahead. Thank you for being part of this extraordinary neonatal community. Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

Calling out "Happy Christmas to all and to all a good-night,  Dr. Griffin and Vincent Racaniello discuss high path influenza in dairy herds in Wisconsin and Marburg virus in Ethiopia before Dr. Griffin then deep dives into recent statistics on the measles epidemic, RSV, influenza and SARS-CoV-2 infections, the Wasterwater Scan dashboard, Johns Hopkins measles tracker, the slightly higher association of COVID-19 infection with death than following influenza infection, benefit of passive infant immunization with niresevimab, association of COVID-19 vaccine immunogenicity protection against severe disease in vulnerable populations, where to find PEMGARDA, how to access and pay for Paxlovid, long COVID treatment center, effect of remdesivir and nirmatrelvir/ritonavir on COVID-19 associated mortality, where to go for answers to your long COVID questions, and contacting your federal government representative to stop the assault on science and biomedical research. Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode USDA Confirms Highly Pathogenic Avian Influenza in a Dairy Herd in Wisconsin (USDA Animal and Plant Health Inspection Service) Update: Genetic Sequencing Results for Wisconsin Dairy Herd Detection of Highly Pathogenic Avian Influenza(USDA Animal and Plant Health Inspection Service) Marburg Outbreak in Ethiopia: Current Situation (CDC: Marburg Virus Disease) Wastewater for measles (WasterWater Scan) Measles cases and outbreaks (CDC Rubeola) Tracking Measles Cases in the U.S. (Johns Hopkins) Measles vaccine recommendations from NYP (jpg) Weekly measles and rubella monitoring (Government of Canada) Measles (WHO) Get the FACTS about measles (NY State Department of Health) Measles(CDC Measles (Rubeola)) Measles vaccine (CDC Measles (Rubeola)) Presumptive evidence of measles immunity (CDC) Contraindications and precautions to measles vaccination (CDC) Adverse events associated with childhood vaccines: evidence bearing on causality (NLM) Measles Vaccination: Know the Facts (ISDA: Infectious Diseases Society of America) Deaths following vaccination: what does the evidence show (Vaccine) Influenza: Waste water scan for 11 pathogens (WastewaterSCan) USrespiratory virus activity (CDC Respiratory Illnesses) Respiratory virus activity levels (CDC Respiratory Illnesses) Weekly surveillance report: clift notes (CDC FluView) In call with clinicians, CDC recommends flu vaccines widely(CIDRAP) Influenza Vaccine Composition for the 2025-2026 U.S. Influenza Season (FDA) Increased 30-day Mortality Risk in Coronavirus Disease 2019 Compared to Seasonal Influenza (International Journal of Infectious Diseases) RSV: Waste water scan for 11 pathogens (WastewaterSCan) Respiratory Diseases (Yale School of Public Health) USrespiratory virus activity (CDC Respiratory Illnesses) RSV-Network (CDC Respiratory Syncytial virus Infection) Vaccines for Adults (CDC: Respiratory Syncytial Virus Infection (RSV)) Economic Analysis of Protein Subunit and mRNA RSV Vaccination in Adults aged 50-59 Years (CDC: ACIP) Nirsevimab vs RSVpreF Vaccine for Respiratory Syncytial Virus–Related Hospitalization in Newborns (JAMA) RSV Immunization Frequently Asked Questions(American Academy of Pediatrics) Waste water scan for 11 pathogens (WastewaterSCan) COVID-19 deaths (CDC) Respiratory Illnesses Data Channel (CDC: Respiratory Illnesses) COVID-19 national and regional trends (CDC) COVID-19 variant tracker (CDC) SARS-CoV-2 genomes galore (Nextstrain) Antigenic and Virological Characteristics of SARS-CoV-2 Variant BA.3.2, XFG, and NB.1.8.1 (bioRxiV) Association between COVID-19 vaccine immunogenicity and protection against infection and severe disease in clinically vulnerable patient populations: a systematic review and meta-analysis of observational studies (Clinical Microbiology and Infection) Where to get pemgarda (Pemgarda) EUAfor the pre-exposure prophylaxis of COVID-19 (INVIYD) Infusion center (Prime Fusions) CDC Quarantine guidelines (CDC) NIH COVID-19 treatment guidelines (NIH) Drug interaction checker (University of Liverpool) Help your eligible patients access PAXLOVID with the PAXCESS Patient Support Program (Pfizer Pro) Understanding Coverage Options (PAXCESS) Infectious Disease Society guidelines for treatment and management (ID Society) The effect of remdesivir and nirmatrelvir/ritonavir on mortality in patients hospitalized with COVID-19 during the Omicron era: an emulated target trial (Clinical Microbiology and Infection) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) What to do when sick with a respiratory virus (CDC) Managing healthcare staffing shortages (CDC) Anticoagulationguidelines (hematology.org) Daniel Griffin's evidence based medical practices for long COVID (OFID) Long COVID hotline (Columbia : Columbia University Irving Medical Center) The answers: Long COVID Long-COVID research just got a big funding boost: will it find new treatments? (Nature) Reaching out to US house representative Letters read on TWiV 1282 Dr. Griffin's COVID treatment summary (pdf) Timestamps by Jolene Ramsey. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv Content in this podcast should not be construed as medical advice.

Endocrine Surgery emergencies are rare. However, they can be clinically significant and understanding how to navigate them as a surgeon in timely fashion is critical. Hosts:  Dr. Rebecca Sippel is an endowed professor of surgery and Division Chief of Endocrine Surgery at University of Wisconsin (UW) - Madison, and she is the most recent past president of the American Association of Endocrine Surgeons (AAES).  She is an internationally recognized leader in the field of endocrine surgery with over 250 publications. She was the principal investigator for a hallmark randomized controlled trial which studied the need for prophylactic central neck dissections in thyroid cancer.   Dr. Amanda Doubleday is a fellowship trained endocrine surgeon in private practice with an affiliation to UW Health. Her primary practice is with Waukesha Surgical Specialists in Waukesha WI. Her clinical interests are in robotic adrenalectomy, benign and malignant thyroid cancer and hyperparathyroidism. Dr. Simon Holoubek is a fellowship trained endocrine surgeon affiliated with UW Health. His primary practice is with UW Health with privileges at UW Madison and UW Northern Illinois. His clinical interests are aggressive variants of thyroid cancer, parathyroid autofluorescence, and nerve monitoring.  Learning Objectives: 1) Learn about thyroid storm in hyperthyroidism and treatment options. 2) Understand how to treat hypercalcemic crisis due to uncontrolled primary hyperparathyroidism. 3) Describe the modified surgical techniques required for thyroidectomy in patients with Graves' disease to prevent recurrent laryngeal nerve traction injury. 4) Identify clinical and intraoperative indicators of parathyroid carcinoma and explain the necessity of en bloc resection to prevent parathyromatosis. References: 1 Palit TK, Miller CC 3rd, Miltenburg DM. The efficacy of thyroidectomy for Graves' disease: A meta-analysis. J Surg Res. 2000 May 15;90(2):161-5. doi: 10.1006/jsre.2000.5875. PMID: 10792958. https://pubmed.ncbi.nlm.nih.gov/10792958/ 2 Yoshimura Noh J, Inoue K, Suzuki N, Yoshihara A, Fukushita M, Matsumoto M, Imai H, Hiruma S, Ichikawa M, Koshibu M, Sankoda A, Hirose R, Watanabe N, Sugino K, Ito K. Dose-dependent incidence of agranulocytosis in patients treated with methimazole and propylthiouracil. Endocr J. 2024 Jul 12;71(7):695-703. doi: 10.1507/endocrj.EJ24-0135. Epub 2024 May 3. PMID: 38710619. https://pubmed.ncbi.nlm.nih.gov/38710619/ 3 Christopher L, Mellman M, Buicko JL. Management of Hypercalcemic Crisis due to Primary Hyperparathyroidism During Pregnancy. Am Surg. 2023 Aug;89(8):3638-3640. doi: 10.1177/00031348231162704. Epub 2023 Apr 27. PMID: 37102502. https://pubmed.ncbi.nlm.nih.gov/37102502/ Sponsor Disclaimer: Visit goremedical.com/btkpod to learn more about GORE® SYNECOR Biomaterial, including supporting references and disclaimers for the presented content. Refer to Instructions for Use at eifu.goremedical.com for a complete description of all applicable indications, warnings, precautions and contraindications for the markets where this product is available. Rx only Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listen Behind the Knife Premium: General Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-review Trauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlas Dominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkship Dominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotation Vascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-audio-review Colorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-audio-review Surgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-audio-review Cardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-audio-review Download our App: Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049 Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US